Understanding migrane in woman

Practitioner

Volumn 246, Issue 1633, 2002, Pages 272-278

  Matharu, Manjit S ^b   Levy, Miles J ^b   Goadsby, Peter J ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT;

CEREBROVASCULAR ACCIDENT; ESTROGEN THERAPY; FEMALE; HUMAN; MENOPAUSE; MENSTRUATION; MIGRAINE; PHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; REVIEW;

ANALGESICS, NON-NARCOTIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CEREBROVASCULAR ACCIDENT; CONTRACEPTIVES, ORAL, COMBINED; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MENOPAUSE; MENSTRUATION; MIGRAINE DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 0036551540     PISSN: 00326518     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8(7):1-96
2. Matharu MS, Boes CJ, Goadsby PJ. Managing the patient with migraine. Practitioner 2001;245:511-321
3. Stewart WF, Shechter A, Rasmussen BK. Migraine prevalence. A review of population-based studies [see [Review] [65 refs]. Neurology 1994;44:S17-23
4. Silberstein SD, Merriam GR. Sex hormones and headache. J Pain Symptom Management 1993;8:98-114
5. Somerville BW. The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology 1972;22:355-365
6. Somerville BW. Estrogen-withdrawal migraine. I. Duration of exposure required and attempted prophylaxis by premenstrual estrogen administration. Neurology 1975;25:239-244
7. Benedetto C. Eicosanoids in primary dysmenorrhoea, endometriosis and menstrual migraine. Gynecol Endocrinol 1985;3:71-94
8. Edelson RN. Menstrual migraine and other hormonal aspects of migraine. Headache 1985;25:376-379
9. Stewart WF, Lipton RB, Chee E, Sawyer J, Silberstein SD. Menstrual cycle and headache in a population sample of migraineurs. Neurology 2000;55:1517-1523
10. Sances G, Martignoni E, Fioroni L, Blandini F, Facchinetti F, Nappi G. Naproxen sodium in menstrual migraine prophylaxis: a double-blind placebo controlled study. Headache 1990;30:705-709
11. Tfelt-Hansen P, Saxena PR, Dahlof C et al. Ergotamine in the acute treatment of migraine: a review and European consensus. Brain 2000;123:9-18
12. Newman L, Mannix LK, Landy S et al. Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study. Headache 2001;41:248-256
13. Pradalier A, Vincent D, Beaulieu PH, Baudesson G, Launay JM. Correlation between oestradiol plasma level and therapeutic effect on menstrual migraine. In: Rose FD (Ed); New Advances in Headache Research. London: Smith-Gordon, 1994
14. Dennerstein L, Morse C, Burrows G, Oats J, Brown J, Smith M. Menstrual migraine: a double-blind trial of percutaneous estradiol. Gynecol Endocrinol 1988;2:113-120
15. Thomas SL, Ellertson C. Nuisance or natural and healthy: should monthly menstruation be optional for women? Lancet 2000;355:922-924
16. Massiou H, MacGregor EA. Evolution and treatment of migraine with oral contraceptives. Cephalalgia 2000;20:170-174
17. MacGregor A. Migraine associated with menstruation. Funct Neurol 2000;15:143-153
18. Sarno AP Jr, Miller EJ Jr, Lundblad EG. Premenstrual syndrome: beneficial effects of periodic, low-dose danazol. Obstet Gynecol 1987;70:33-36
19. O'Dea JP, Davis EH. Tamoxifen in the treatment of menstrual migraine. Neurology 1990;40:1470-1471
20. Herzog AG. Continuous bromocriptine therapy in menstrual migraine. Neurology 1997;48:101-102
21. Darney PD, Atkinson E, Tanner S, MacPherson S, Hellerstein S, Alvarado A. Acceptance and perceptions of NORPLANT among users in San Francisco, USA. Stud Fam Plann 1990;21:152-160
22. Bousser MG, Conard J, Kittner S et al. Recommendations on the risk of ischaemic stroke associated with use of combined oral contraceptives and hormone replacement therapy in women with migraine. The International Headache Society Task Force on Combined Oral Contraceptives & Hormone Replacement Therapy. Cephalalgia 2000;20:155-156
23. Tzourio C, Kittner SJ, Bousser MG, Alperovitch A. Migraine and stroke in young women. Cephalalgia 2000;20:190-199
24. Bousser MG, Kittner SJ. Oral contraceptives and stroke. Cephalalgia 2000;20:183-189
25. WHO. Improving access to quality care in family planning. Medical eligibility criteria for initiating and continuing use of contraceptive methods. Geneva: WHO, 1996
26. MacGregor EA, Guillebaud J. Combined oral contraceptives, migraine and ischaemic stroke. Clinical and Scientific Committee of the Faculty of Family Planning and Reproductive Health Care and the Family Planning Association. Br J Fam Plann 1998;24:55-60
27. Silberstein SD. Migraine and pregnancy. Neurologic Clinics 1997;15:209-231
28. Chancellor AM, Wroe SJ, Cull RE. Migraine occurring for the first time in pregnancy. Headache 1990;30:224-7
29. MacGregor A (Ed). Migraine and pregnancy. In: Migraine in Women. London: Martin Dunitz, 1999:61-69
30. Fox AW, Chambers CD, Anderson PO, Diamond ML, Spierings ELH. Evidence-based assessment of pregnancy outcome after sumatriptan exposure. Headache 2002;42:8-15
31. Neri I, Granella F, Nappi R, Manzoni GC, Facchinetti F, Genazzani AR. Characteristics of headache at menopause: a clinico-epidemiologic study. Maturitas 1993;17:31-37
32. Becker WJ. Migraine and oral contraceptives. Can J Neurol Sci 1997;24:16-21
33. Kittner SJ, Stem BJ, Feeser BR et al. Pregnancy and the risk of stroke. N Engl J Med 1996;335:768-774
34. Silberstein SD, de Lignieres B. Migraine, menopause and hormonal replacement therapy. Cephalalgia 2000;20:214-221